Polymorphisms in Human MDR1 (P‐glycoprotein): Recent Advances and Clinical Relevance

C Marzolini, E Paus, T Buclin… - Clinical Pharmacology & …, 2004 - Wiley Online Library
Drug transporters are increasingly recognized to be important to drug disposition and
response. P‐glycoprotein, the encoded product of the human MDR1 (ABCB1) gene, is of …

Multifactorial etiology of gastric cancer

J Zabaleta - Cancer Epigenetics: Methods and Protocols, 2012 - Springer
The prevalence of gastric cancer is associated with several factors including geographical
location, diet, and genetic background of the host. However, it is evident that infection with …

The effect of CYP3A5 and MDR1 (ABCB1) polymorphisms on cyclosporine and tacrolimus dose requirements and trough blood levels in stable renal transplant …

V Haufroid, M Mourad, V Van Kerckhove… - Pharmacogenetics …, 2004 - journals.lww.com
Cyclosporine and tacrolimus are immunosuppressive drugs largely used in renal
transplantation. They are characterized by a wide inter-individual variability in their …

Implications of genetic polymorphisms in drug transporters for pharmacotherapy

R Kerb - Cancer letters, 2006 - Elsevier
Drug transporters are increasingly recognized as a key determinant of drug disposition and
response. It is now widely appreciated that expression of the ATP-dependent efflux …

Differences in drug pharmacokinetics between East Asians and Caucasians and the role of genetic polymorphisms

K Kim, JA Johnson, H Derendorf - The Journal of Clinical …, 2004 - Wiley Online Library
Interethnic variability in pharmacokinetics can cause unexpected outcomes such as
therapeutic failure, adverse effects, and toxicity in subjects of different ethnic origin …

Microparticles and their emerging role in cancer multidrug resistance

J Gong, R Jaiswal, JM Mathys, V Combes… - Cancer treatment …, 2012 - Elsevier
Drug resistance is a major obstacle to the successful treatment of cancer as tumor cells
either fail to reduce in size following chemotherapy or the cancer recurs after an initial …

An up-date review on individualized dosage adjustment of calcineurin inhibitors in organ transplant patients

S Masuda, K Inui - Pharmacology & therapeutics, 2006 - Elsevier
Calcineurin inhibitors, tacrolimus (FK506) and cyclosporine (ciclosporin A), are the primary
immunosuppressive agents used on recipients of organ transplantations. The hepatic …

Pharmacogenomics and COVID-19: clinical implications of human genome interactions with repurposed drugs

OA Badary - The pharmacogenomics journal, 2021 - nature.com
The outbreak of Coronavirus disease 2019 (COVID-19) has evolved into an emergent global
pandemic. Many drugs without established efficacy are being used to treat COVID-19 …

MDR1 genotype-related pharmacokinetics: fact or fiction?

T Sakaeda - Drug metabolism and pharmacokinetics, 2005 - jstage.jst.go.jp
Multidrug resistant transporter MDR1WP-glycoprotein, the gene product of MDR1, is a
glycosylated membrane protein of 170 kDa, belonging to the ATP-binding cassette …

Population pharmacokinetics of cyclosporine in kidney and heart transplant recipients and the influence of ethnicity and genetic polymorphisms in the MDR‐1 …

DA Hesselink, T van Gelder… - Clinical …, 2004 - Wiley Online Library
Objective Our objective was to determine the relationship between single nucleotide
polymorphisms (SNPs) in the multidrug resistance 1 (MDR‐1) gene and the cytochrome …